Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: Comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA

Journal of Magnetic Resonance Imaging

Volumn 29, Issue 3, 2009, Pages 636-640

  Tamada, Tsutomu ^a   Ito, Katsuyoshi ^a   Sone, Teruki ^a   Yamamoto, Akira ^a   Yoshida, Koji ^a   Kakuba, Koki ^a   Tanimoto, Daigo ^a   Higashi, Hiroki ^a   Yamashita, Takenori ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Comparative studies; Contrast enhancement; Contrast media; Gd DTPa; Gd EOB DTPA; Liver; Magnetic resonance(MR)

Indexed keywords

GADOLINIUM PENTETATE; GADOXETIC ACID;

ABDOMEN; ADRENAL GLAND; ADULT; AORTA; ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; GASTROINTESTINAL TRACT; HUMAN; HUMAN EXPERIMENT; INFERIOR CAVA VEIN; KIDNEY CORTEX; KIDNEY MEDULLA; LIVER; LIVER PARENCHYMA; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS; PORTAL VEIN; PRIORITY JOURNAL; SPLEEN;

ABDOMEN; ADRENAL GLANDS; ADULT; AORTA; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; KIDNEY; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PANCREAS; PORTAL VEIN; REFERENCE VALUES; SPLEEN; VENA CAVA, INFERIOR;

EID: 63449137930     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21689     Document Type: Article

References (22)

1. Clement O. Muhler A, Vexler VS, et al. Comparison of Gd-EOB- DTPA and Gd-DTPA for contrast-enhanced MR imaging of liver tumors. J Magn Reson Imaging 1993;3:71-77.
2. Fujita T, Honjo K, Ito K, Matsumoto T, Matsunaga N, Hamm B. High-resolution dynamic MR imaging of hepatocellular carcinoma with a phased-array body coil. Radiographics 1997;17:315-331.
3. Ito K, Mitchell DG, Honjo K, et al. Biphasic contrast-enhanced multisection dynamic MR imaging of the liver: potential pitfalls. Radiographics 1997;17:693-705.
4. Hamm B, Wolf KJ, Felix R. Conventional and rapid MR imaging of the liver with Gd-DTPA. Radiology 1987;164:313-320.
5. Marchal G, Demaerel P, Decrop E, Van Hecke P, Baert AL. Gado-linium-DOTA enhanced fast imaging of liver tumors at 1.5 T. J Comput Assist Tomogr 1990;14:217-222.
6. Hamm B, Staks T, Muhler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, phar-macokinetics, and MR imaging. Radiology 1995;195:785-792.
7. Reimer P, Rummeny EJ, Shamsi K, et al. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 1996;199:177-183.
8. Vogl TJ, Kummel S, Hammerstingl R, et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996;200:59-67.
9. Clement O, Muhler A, Vexler V, Berthezene Y, Brasch RC. Gadolin-ium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonancecontrast agent. Kinetic and enhancement patterns in normal and cholestatic rats. Invest Radiol 1992;27:612-619.
10. Weinmann HJ, Schuhmann-Giampieri G, Schmitt-Willich H, Vo-gler H, Frenzel T, Gries H. A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Magn Reson Med 1991;22:233-237
11. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992;183:59-64.
12. Muhler A, Clement O, Vexler V, Berthezeene Y, Rosenau W, Brasch RC. Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases. Radiology 1992;184:207-213.
13. Muhler A, Heinzelmann I, Weinmann HJ. Elimination of gadolini-um- ethoxybenzyl-DTPA in a rat model of severely impaired liver and kidney excretory function. An experimental study in rats. Invest Radiol 1994;29:213-216.
14. Reimer P, Rummeny EJ, Daldrup HE, et al. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hem-angiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol 1997;7:275-280.
15. Vogt FM, Antoch G, Hunold P, et al. Parallel acquisition techniques for accelerated volumetric interpolated breath-hold examination magnetic resonance imaging of the upper abdomen: assessment of image quality and lesion conspicuity. J Magn Reson Imaging 2005;21:376-382.
16. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999;212:876-884.
17. McKenzie CA, Lim D, Ransil BJ, et al. Shortening MR image acquisition time for volumetric interpolated breath-hold examination with a recently developed parallel imaging reconstruction technique: clinical feasibility. Radiology 2004;230:589-594.
18. Kwak HS, Lee JM, Kim YK, Lee YH, Kim CS. Detection of hepato-cellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging. Eur Radiol 2005;15:140-147.
19. Bluemke DA, Sahani D, Amendola M, et al. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology 2005;237:89-98.
20. Huppertz A, Balzer T, Blakeborough, et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison ofgadox- etic acid-enhanced MR images with intraoperative findings. Radiology 2004;230:266-275.
21. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005;40:715-724.
22. Huppertz A, Haraida S, Kraus A, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology 2005;234:468-478.